Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

A tool to help women with substance use disorders make reproductive decisions after childbirth

Official title: Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period

Run by University of Pittsburgh · NCT04939012 · Data updated 2026-11-12

This study is testing a new tool called MyPath to help women with substance use disorders make better choices about birth control after having a baby.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment400 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedOctober 11, 2022
Main results expectedMarch 1, 2027
Study endsMarch 1, 2027
Registry record updatedFebruary 17, 2026
Trial IDNCT04939012 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 and older who are pregnant or within 9 days postpartum and have a substance use disorder.

Probably not a fit

Patients who have experienced fetal or neonatal death in their current pregnancy or are currently incarcerated may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of MyPath, a patient-centered decision support tool designed to improve postpartum contraceptive decision-making among women with substance use disorders (SUDs). The research addresses the high rates of unintended pregnancies in this population by providing tailored reproductive planning support during a critical period of increased healthcare access. Participants will receive either the MyPath intervention or usual care, with the goal of enhancing their contraceptive choices and aligning them with their reproductive goals. The study aims to fill a significant gap in postpartum care for women with SUDs, who often face barriers to effective contraceptive use.

Why it matters

Potential benefit: If successful, this tool could significantly reduce unintended pregnancies among women with substance use disorders.

How similar studies have gone: While there is limited research specifically targeting this approach, the study builds on previous observational findings regarding contraceptive choices in women with opioid use disorder.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Prenatal Cohort:

* Be greater than or equal to 18 years of age.
* Be pregnant with an EGA of 22 to 37 weeks at enrollment.
* Plan to deliver at research site.
* Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.

Postpartum Cohort:

* Be greater than or equal to 18 years of age.
* Be 0-9 days postpartum at enrollment.
* Have delivered at research site.
* Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.

Exclusion Criteria:

* Have had a fetal or neonatal death with their current pregnancy.
* Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.
* Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation.
* PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization

Where it's running

  • Magee Womens Hospital of UPMC
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Elizabeth Krans, MD — University of Pittsburgh
  • Study coordinator: Elizabeth Krans, MD
  • Email: kransee@upmc.edu
  • Phone: (412) 641-3532

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.